<DOC>
	<DOCNO>NCT01033578</DOCNO>
	<brief_summary>The aim study assess efficacy different adjuvant chemotherapy strategy hepatectomy thrombectomy hepatocellular carcinoma ( HCC ) portal vein tumor thrombosis ( PVTT ) .</brief_summary>
	<brief_title>Efficacy Postoperative Adjuvant Treatments Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis</brief_title>
	<detailed_description>Hepatocellular carcinoma ( HCC ) sixth common cancer worldwide third major cause cancer-related death . HCC characterize propensity portal vein invasion . Portal vein tumor thrombosis ( PVTT ) detect macroscopically portal vein 44 % 62.2 % autopsy case . The natural history untreated HCC PVTT dismal . The median survival patient report 2.7 mouth . Non-surgical therapy , systemic/regional chemotherapy transcatheter arterial embolization / transcatheter arterial chemoembolization ( TAE/TACE ) , effective treat HCC PVTT . With improvement surgical technique , surgical resection report achieve promising result . However , high rate recurrence metastasis constitute one important challenge improve surgical efficacy HCC PVTT . There rare report prevention treatment postoperative recurrence metastasis HCC macroscopical PVTT patient . We previously find postoperative portal vein infusion chemotherapy ( PVIC ) TACE benefit PVTT patient , require prospective randomize control study large case number support finding . The randomized controlled trial design investigate efficacy different adjuvant chemotherapy strategy hepatectomy thrombectomy HCC PVTT .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Liposomal doxorubicin</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Doxorubicin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>1 . Age 18 75 year 2 . Hepatocellular carcinoma portal vein tumor thrombosis first branch and/or main trunk portal vein confirm preoperative radiologic investigation , intraoperative exploration postoperative pathology . 3 . No extrahepatic metastasis 4 . No previous management 5 . The tumor PVTT completely remove confirm macroscopy intraoperative ultrasonography 6 . Good moderate hepatic function ( ChildPugh Class A B ) 7 . Eastern Cooperative Oncology Group ( ECOG ) performance status 2 less 1 . Refuse participate 2 . Absolute neutrophil count &lt; 1.5*109/L , hemoglobin &lt; 80g/L platelet count &lt; 50 * 109/L , transaminase great 3 time upper limit normal , serum creatinine great 1.5 time upper limit normal , INR great 1.5 time normal , could recover treatment 3 . Ascites refractory diuretic 4 . Variceal bleed 5 . Severe disease heart Lung</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>